Status:

COMPLETED

The Effect of Ozone Treatment on Coronary Flow Reserve in Patients With Heart Failure Having Reduced Ejection Fraction

Lead Sponsor:

Ekrem Bilal Karaayvaz

Conditions:

Heart Failure and Reduced Ejection Fraction

Eligibility:

All Genders

40-80 years

Phase:

NA

Brief Summary

The goal of this clinical trial is to determine the effect of ozone treatment in heart failurte with reduced ejection fraction. The main questions it aims to answer are: Does ozone treatment have ben...

Detailed Description

Patients who were previously scheduled for ozone therapy at the ozone therapy clinic of Medicana International Hospital Istanbul for another indication that did not affect the endothelial function of ...

Eligibility Criteria

Inclusion

  • Previosuly known coronary angiography with less than % 50 stenosis
  • Echocardiography with ejection fraction of less than % 40
  • Patients with previosly planned for ozone treatment for non-chronic disease or conditions

Exclusion

  • Known chronic diseases or conditions that effect endothelial functions.
  • Previosly had acute coronary syndrome or stent implantation or any coronary intervention.
  • Smokers

Key Trial Info

Start Date :

January 14 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 21 2024

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT07134972

Start Date

January 14 2024

End Date

December 21 2024

Last Update

September 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medicana International Hospital Istanbul

Istanbul, Turkey (Türkiye)